JIANMING XU to Tumor Cells, Cultured
This is a "connection" page, showing publications JIANMING XU has written about Tumor Cells, Cultured.
Connection Strength
0.141
-
Genetic screening reveals an essential role of p27kip1 in restriction of breast cancer progression. Cancer Res. 2007 Sep 01; 67(17):8032-42.
Score: 0.062
-
Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism. J Biol Chem. 1995 Mar 17; 270(11):6308-13.
Score: 0.026
-
Genomic structure and cloned cDNAs predict that four variants in the kinase domain of serine/threonine kinase receptors arise by alternative splicing and poly(A) addition. Proc Natl Acad Sci U S A. 1994 Aug 16; 91(17):7957-61.
Score: 0.025
-
Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator activity by I kappa B kinase. Mol Cell Biol. 2002 May; 22(10):3549-61.
Score: 0.011
-
Control of fibroblast growth factor receptor kinase signal transduction by heterodimerization of combinatorial splice variants. Mol Cell Biol. 1993 Jul; 13(7):3907-18.
Score: 0.006
-
A widely expressed transmembrane serine/threonine kinase that does not bind activin, inhibin, transforming growth factor beta, or bone morphogenic factor. J Biol Chem. 1993 Jun 15; 268(17):12719-23.
Score: 0.006
-
16-kilodalton heparin binding (fibroblast) growth factor type one appears in a stable 40-kilodalton complex after receptor-dependent internalization. J Biol Chem. 1991 Mar 25; 266(9):5774-9.
Score: 0.005